A Future Market Insights report found the spine biologics market will grow between 2016 and 2026, according to medGadget.
Here are five observations:
1. Technology advancements and demand for minimally invasive surgery will spur the spine biologics market growth.
2. Additionally, the aging population, rising prevalence of disease and increasing government funding will also boost the market.
3. North America currently possesses the largest market share, but the Asia-Pacific region will likely see the most growth due to high populations.
4. The costliness of procedures as well as the availability of substitute products will serve as barriers to market growth.
5. Alphatec Spine, Medtronic, Zimmer Biomet, Globus Medical, Exactech, RTI Biologics, Small Bone Innovations, Stryker, Amedica, K2M, NuVasive, Precision Spine and TranS1 represent leaders in the market.